Target Amount
$10,000
Deadline
Mar 16, 2023
Issuer
iMetabolic Biopharma Corporation
Location
2155 e conference dr ste 115
tempe, arizona, united states
About
Early stage precision medicine biopharma company focusing on obesity related disease, with specific emphasis on cardiovascular disease.
Campaign Ended
Ended 917 days ago